Newsroom

By Dr. Jordan Messler November 27, 2023 Simply put, there’s no turning back from the digital transformation that’s underway and continuing to pick up steam. This is why it’s critical for the people who design and use healthcare technology to always consider the influence it can have. Technology has become embedded in almost every part of healthcare, and the ways we rely on it to help deliver...

FEBRUARY 2021 Jordan Messler, MD, SFHM, FACP The implementation of Electronic Health Records (EHR) following the government mandate more than a decade ago hasn’t always been easy, but it can be a game-changer when it comes to real-time patient data management. While EHRs drastically simplify the access to patient-specific data, information overload and inefficient usage often leave providers...

MAY 16, 2019 Glytec Awarded Patent Allowance for Virtual Insulin Titration in Concert with CGM, Smart Pens and Other Diabetes Technologies The company’s growing intellectual property portfolio attests to its leadership position in diabetes medication optimization in an era of data-driven care. Waltham, MA — Glytec, the pioneer of digital therapeutics, has been awarded another patent allowance by...

AUGUST 29, 2018 Glytec Receives Two More Patent Allowances for its Insulin Optimization System The newest USPTO allowances describe an integrated, connected care model for optimizing insulin therapy in the outpatient setting. Waltham, MA — The United States Patent and Trademark Office has awarded Glytec two more patent allowances acknowledging the unique characteristics of its disruptive...

JANUARY 5, 2018 Glytec Awarded Patent Allowance Supporting Connected Care Model for Insulin Management The allowed patent encompasses detailed interactions between multiple connected diabetes technologies. Waltham, MA — Glytec, the pioneer of personalized digital therapeutics, has been awarded another U.S. patent allowance for systems and methods related to insulin management in the outpatient...

JUNE 29, 2017 Glytec Receives Five Additional Patent Allowances for its Diabetes Therapy Management Software Poised to address diabetes on a global scale, the company expands its intellectual property protections in the United States and abroad. WALTHAM, MA — Glytec, the healthcare company behind a market-leading software solution for personalized diabetes therapy management, announces five new...

DECEMBER 15, 2016 Glytec Grows its Patent Portfolio with Another Notice of Allowance for its Precision Diabetes Management Technologies This latest notice of allowance from the United States Patent and Trademark Office deepens Glytec’s intellectual property protections and further validates its leadership stature in the healthcare market. Waltham, MA — Glytec today announces another notice of...

SEPTEMBER 27, 2016 Glytec Receives Three Additional Patent Notices of Allowance from USPTO for its Breakthrough Diabetes Technologies The notices further validate Glytec’s position as a leader in advanced technologies and innovations for glycemic management. Waltham, MA — Glytec today announces notices of allowance received from the United States Patent and Trademark Office (USPTO) for three...

The allowed claims are directed to a system for glycemic control of a diabetic patient that includes a smartphone-based diabetes mobile application, which will provide patients with real-time insulin dosing guidance, leveraging Glytec’s proprietary insulin titration technology. Waltham, MA — Glytec, the pioneer and leader in providing innovative glucose management software solutions,...